Harsimran Sachdeva Singh

Dr. Harsimran Sachdeva Singh

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
PVPrashanth Venkatesh
Prashanth Venkatesh
AEArthur T. Evans
Arthur T. Evans
AMAnna M. Maw
Anna M. Maw
RPRaymond Anthony Pashun
Raymond Anthony Pashun
APAgam Patel
Agam Patel
HSHarsimran Sachdeva Singh
Harsimran Sachdeva Singh
Background: Existing data on predictors of late mortality and prevention of sudden cardiac death after atrial switch repair surgery for D‐transposition of the great arteries (D‐ TGA ) are heterogeneous and limited by statistical power. Methods and Results: We conducted a systematic review and meta‐analysis of 29 observational studies, comprising 5035 patients, that reported mortality after atrial switch repair with a minimum follow‐up of 10 years. We also examined 4 additional studies comprising 105 patients who reported rates of implantable cardioverter‐defibrillator therapy in this population. Average survival dropped to 65% at 40 years after atrial switch repair , with sudden cardiac death accounting for 45% of all reported deaths. Mortality was significantly lower in cohorts that were more recent and operated on younger patients. Patient‐level risk factors for late mortality were history of supraventricular tachycardia ( odds ratio [OR] 3.8, 95% CI 1.4–10.7), Mustard procedure compared with Senning ( OR 2.9, 95% CI 1.9–4.5) and complex D‐ TGA compared with simple D‐ TGA ( OR 4.4, 95% CI 2.2–8.8). Significant risk factors for sudden cardiac death were history of supraventricular tachycardia ( OR 4.7, 95% CI 2.2–9.8), Mustard procedure ( OR 2.2, 95% CI 1.1–4.1), and complex D‐ TGA ( OR 5.7, 95% CI 1.8–18.0). Out of a total 124 implantable cardioverter‐defibrillator discharges over 330 patient‐years in patients with implantable cardioverter‐defibrillator s for primary prevention, only 8% were appropriate. Conclusions: Patient‐level risk of both mortality and sudden cardiac death after atrial switch repair are significantly increased by history of supraventricular tachycardia , Mustard procedure, and complex D‐ TGA . This knowledge may help refine current selection practices for primary prevention implantable cardioverter‐defibrillator implantation, given disproportionately high rates of inappropriate discharges.

1 January 2018 in The American Journal of Medicine
Verified
Journal Article
Closed access
UKUdhay Krishnan
Udhay Krishnan
JBJosef A. Brejt
Josef A. Brejt
JSJoshua Schulman-Marcus
Joshua Schulman-Marcus
RSRajesh V. Swaminathan
Rajesh V. Swaminathan
DFDmitriy N. Feldman
Dmitriy N. Feldman
LKLuke K. Kim
Luke K. Kim

1 June 2019 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
SWShing Chiu Wong
Shing Chiu Wong
IYIlhwan Yeo
Ilhwan Yeo
GBGeoffrey Bergman
Geoffrey Bergman
DFDmitriy N. Feldman
Dmitriy N. Feldman
HSHarsimran Sachdeva Singh
Harsimran Sachdeva Singh
LKLuke K. Kim
Luke K. Kim

26 June 2018 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
JKJared Kirzner
Jared Kirzner
APAltaf Pirmohamed
Altaf Pirmohamed
JGJonathan Ginns
Jonathan Ginns
HSHarsimran Sachdeva Singh
Harsimran Sachdeva Singh

1 January 2019 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
YWYan Wen
Yan Wen
JWJonathan W. Weinsaft
Jonathan W. Weinsaft
TNThanh Nguyen
Thanh Nguyen
ZLZhe Liu
Zhe Liu
EHEvelyn M. Horn
Evelyn M. Horn
PSPascal Spincemaille
Pascal Spincemaille
Differential blood oxygenation between left (LV) and right ventricles (RV; ΔSaO2) is a key index of cardiac performance; LV dysfunction yields increased RV blood pool deoxygenation. Deoxyhemoglobin increases blood magnetic susceptibility, which can be measured using an emerging cardiovascular magnetic resonance (CMR) technique, Quantitative Susceptibility Mapping (QSM) – a concept previously demonstrated in healthy subjects using a breath-hold 2D imaging approach (2DBHQSM). This study tested utility of a novel 3D free-breathing QSM approach (3DNAVQSM) in normative controls, and validated 3DNAVQSM for non-invasive ΔSaO2 quantification in patients undergoing invasive cardiac catheterization (cath). Initial control (n = 10) testing compared 2DBHQSM (ECG-triggered 2D gradient echo acquired at end-expiration) and 3DNAVQSM (ECG-triggered navigator gated gradient echo acquired in free breathing using a phase-ordered automatic window selection algorithm to partition data based on diaphragm position). Clinical testing was subsequently performed in patients being considered for cath, including 3DNAVQSM comparison to cine-CMR quantified LV function (n = 39), and invasive-cath quantified ΔSaO2 (n = 15). QSM was acquired using 3 T scanners; analysis was blinded to comparator tests (cine-CMR, cath). 3DNAVQSM generated interpretable QSM in all controls; 2DBHQSM was successful in 6/10. Among controls in whom both pulse sequences were successful, RV/LV susceptibility difference (and ΔSaO2) were not significantly different between 3DNAVQSM and 2DBHQSM (252 ± 39 ppb [17.5 ± 3.1%] vs. 211 ± 29 ppb [14.7 ± 2.0%]; p = 0.39). Acquisition times were 30% lower with 3DNAVQSM (4.7 ± 0.9 vs. 6.7 ± 0.5 min, p = 0.002), paralleling a trend towards lower LV mis-registration on 3DNAVQSM (p = 0.14). Among cardiac patients (63 ± 10y, 56% CAD) 3DNAVQSM was successful in 87% (34/39) and yielded higher ΔSaO2 (24.9 ± 6.1%) than in controls (p < 0.001). QSM-calculated ΔSaO2 was higher among patients with LV dysfunction as measured on cine-CMR based on left ventricular ejection fraction (29.4 ± 5.9% vs. 20.9 ± 5.7%, p < 0.001) or stroke volume (27.9 ± 7.5% vs. 22.4 ± 5.5%, p = 0.013). Cath measurements (n = 15) obtained within a mean interval of 4 ± 3 days from CMR demonstrated 3DNAVQSM to yield high correlation (r = 0.87, p < 0.001), small bias (− 0.1%), and good limits of agreement (±8.6%) with invasively measured ΔSaO2. 3DNAVQSM provides a novel means of assessing cardiac performance. Differential susceptibility between the LV and RV is increased in patients with cine-CMR evidence of LV systolic dysfunction; QSM-quantified ΔSaO2 yields high correlation and good agreement with the reference of invasively-quantified ΔSaO2.

1 September 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JSJoshua Schulman-Marcus
Joshua Schulman-Marcus
TSTara Shah
Tara Shah
RSRajesh V. Swaminathan
Rajesh V. Swaminathan
DFDmitriy N. Feldman
Dmitriy N. Feldman
SWShing-Chiu Wong
Shing-Chiu Wong
LKLuke K. Kim
Luke K. Kim